.Pharmacolibrary.Drugs.D_Dermatologicals.D10A_AntiAcnePreparationsForTopicalUse.D10AF02_Erythromycin.Erythromycin

Information

Erythromycin is a macrolide antibiotic used to treat various bacterial infections, especially in individuals allergic to penicillins. It is effective against respiratory tract, skin, and soft tissue infections and is still approved and used in clinical practice today.

Pharmacokinetics

Pharmacokinetic parameters in healthy adult volunteers after oral administration.

References

1. Bizjak, ED, & Mauro, VF (1997). Digoxin-macrolide drug interaction. The Annals of pharmacotherapy 31(9) 1077–1079. DOI:10.1177/106002809703100918 PUBMED:https://pubmed.ncbi.nlm.nih.gov/9296249

2. Yu, KS, et al., & Shin, SG (2001). Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycin. Clinical pharmacology and therapeutics 70(3) 228–236. DOI:10.1067/mcp.2001.117703 PUBMED:https://pubmed.ncbi.nlm.nih.gov/11557910

3. Hall, KW, et al., & DiSanto, AR (1982). Pharmacokinetics of erythromycin in normal and alcoholic liver disease subjects. Journal of clinical pharmacology 22(7) 321–325. DOI:10.1002/j.1552-4604.1982.tb02682.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/7107981

Revisions

• 06/2025 initial generated model